78 related articles for article (PubMed ID: 27648286)
1. Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin.
Levin PA; Heinemann L; Boss A; Rosenblit PD
BMJ Open Diabetes Res Care; 2016; 4(1):e000228. PubMed ID: 27648286
[TBL] [Abstract][Full Text] [Related]
2. Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
Steiner S; Pfützner A; Wilson BR; Harzer O; Heinemann L; Rave K
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):17-21. PubMed ID: 11835120
[TBL] [Abstract][Full Text] [Related]
3. Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.
McElduff A; Mather LE; Kam PC; Clauson P
Br J Clin Pharmacol; 2005 May; 59(5):546-51. PubMed ID: 15842553
[TBL] [Abstract][Full Text] [Related]
4. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
5. Technosphere inhaled insulin (Afrezza).
Rendell M
Drugs Today (Barc); 2014 Dec; 50(12):813-27. PubMed ID: 25588086
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine.
Potocka E; Cassidy JP; Haworth P; Heuman D; van Marle S; Baughman RA
J Diabetes Sci Technol; 2010 Sep; 4(5):1164-73. PubMed ID: 20920436
[TBL] [Abstract][Full Text] [Related]
7. Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.
Haller MJ; Jones MC; Bhavsar S; Kaiserman KB
Diabetes Ther; 2023 Mar; 14(3):611-617. PubMed ID: 36652106
[TBL] [Abstract][Full Text] [Related]
8. Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.
Rave K; Heise T; Heinemann L; Boss AH
J Diabetes Sci Technol; 2008 Mar; 2(2):205-12. PubMed ID: 19885344
[TBL] [Abstract][Full Text] [Related]
9. Place of technosphere inhaled insulin in treatment of diabetes.
Mikhail N
World J Diabetes; 2016 Dec; 7(20):599-604. PubMed ID: 28031777
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
11. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
[TBL] [Abstract][Full Text] [Related]
13. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
[TBL] [Abstract][Full Text] [Related]
14. Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage.
Kaiserman KB; Christiansen M; Bhavsar S; Ulloa J; Santogatta B; Hanna J; Bailey TS
J Diabetes Sci Technol; 2024 Mar; 18(2):397-401. PubMed ID: 35833638
[TBL] [Abstract][Full Text] [Related]
15. Fumaryl Diketopiperazine Microspheres Platform Design for Protein Pulmonary Delivery in Diabetes Rats Model.
Shen Y; Lu M; Liu J; Tu J; Yin Y; Li W
J Biomed Nanotechnol; 2020 Aug; 16(8):1241-1253. PubMed ID: 33397554
[TBL] [Abstract][Full Text] [Related]
16. Technosphere insulin technology.
Richardson PC; Boss AH
Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S65-72. PubMed ID: 17563306
[TBL] [Abstract][Full Text] [Related]
17. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
[TBL] [Abstract][Full Text] [Related]
18. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
19. Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.
Henry RR; Mudaliar S; Chu N; Kim D; Armstrong D; Davis TT; An B; Reinhardt RR
J Clin Pharmacol; 2003 Nov; 43(11):1228-34. PubMed ID: 14551177
[TBL] [Abstract][Full Text] [Related]
20. Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
Pfützner A; Mann AE; Steiner SS
Diabetes Technol Ther; 2002; 4(5):589-94. PubMed ID: 12450439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
